JGP Global Gestao de Recursos Ltda.
SEC Form 13F institutional filer · CIK 0001536562
13F-HR · 14 reported holdings · 2026-03-31
Reported long-US-equity value
$0.01B
Top-10 concentration
84.2%
JGP Global Gestao de Recursos Ltda. — $5.73M AUM allocation strategy
JGP Global Gestao de Recursos Ltda. files SEC Form 13F and reports $5.73M of long US equity value across 14 reported holdings for 2026-03-31.
Its largest sector bet is Health Care 95.4%, followed by Information Technology 4.6%.
The top 10 holdings account for 84% of reported value — a conviction-weighted book concentrated in its best ideas. The sector and industry splits below are of the same reported value. Track quarter-over-quarter adds, trims, new positions and exits below — sourced from SEC 13F filings, public domain.
JGP Global Gestao de Recursos Ltda. — latest SEC 13F insights
Reported long-US-equity value (13F AUM)
$5.73M
total across 14 reported holdings · 2026-03-31 · excludes shorts, cash, non-US
Top-10 concentration
84% of value
higher = narrower conviction; lower = spread / hedging
Added from nil (new positions)
None this quarter
Exited to nil (held last quarter, gone now)
$QTOP ($1.15M last qtr)$SO ($531K last qtr)$GOOGL ($249K last qtr)$IDXX ($231K last qtr)$AVGO ($211K last qtr)
Sector allocation (share of reported value)
each slice is a share of the reported long-US-equity value — smaller sectors and the rest of the book roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Industry allocation (share of reported value)
- Pharmaceuticals39.1%—
- Biotechnology30.8%—
- Health Care Equipment15.2%—
- Life Sciences Tools & Services6.0%—
- Semiconductors4.6%—
- Health Care Distributors4.3%—
the finer GICS cut of the same book — same denominator — smaller industries roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Top S&P 500 holdings
10 of 10 rows · sorted by Value ↓
| Ticker | Holding | Shares | Value | Δ QoQ | Weight |
|---|---|---|---|---|---|
| $LLY | Eli Lilly and Company | 1.23K | $1.13M | +13 | 19.8% |
| $ABBV | AbbVie Inc | 3.07K | $668K | +15 | 11.7% |
| $INCY | Incyte Corp | 5.62K | $529K | -3.47K | 9.2% |
| $JNJ | Johnson & Johnson | 2.13K | $521K | +9 | 9.1% |
| $BMY | Bristol-Myers Squibb Company | 6.16K | $374K | +26 | 6.5% |
| $TMO | Thermo Fisher Scientific Inc | 704 | $346K | +6 | 6.0% |
| $ISRG | Intuitive Surgical Inc | 750 | $346K | +7 | 6.0% |
| $GILD | Gilead Sciences Inc | 2.33K | $325K | +9 | 5.7% |
| $ABT | Abbott Laboratories | 3.09K | $318K | +36 | 5.5% |
| $NVDA | NVIDIA Corporation | 1.52K | $265K | -883 | 4.6% |
…and 4 more holdings in the full 13F filing (top positions only shown).
SEC Form 13F data sets · public domain · 45-day filing lag · >$100M AUM managers · as reported
← All 13F filers·← QuantOrb.pro
How to read Δ QoQ — the five insight categories, and the caveats
The categories. Analysts, quants and retail traders look past total portfolio value to isolate actionable signals. Five categories matter.
Conviction & concentration shifts
New positions vs complete exits — a brand-new stock signals high conviction; a full liquidation suggests a broken thesis or tax-loss harvesting. Aggressive sizing — look at share count, not dollars: a 20% share increase during a drawdown is strong dip-buying. Concentration — a narrowing top-5/10 means conviction; spreading capital across more names means hedging.
Sector & macro allocation rotations
Aggregating Δ QoQ moves across sectors shows where smart money is leaning in or sneaking out — rotating out of growth into defensives or energy, for example. The fund's total long equity exposure quarter-over-quarter is a proxy for overall institutional risk appetite.
Crowding & smart-money consensus
When several managers initiate or expand the same stock in the same quarter, that is institutional consensus. Contrarian reads: top pickers buying hard into a beaten-down name the market is selling.
Derivative & option overlays
Reported call/put changes indicate whether managers are adding downside hedges or leveraging upside exposure. Note: a long increase may be half of a market-neutral pair trade.
Who reads this
| Retail "cloners" | High-conviction ideas to replicate ~45 days after quarter-end. |
| Corporate IR | Which funds bought or dumped the stock, before the next call. |
| Quant / algo traders | Cross-sectional factor inputs: flow, momentum, ownership. |
Four caveats before you trade on it
- 45-day lag — holdings are quarter-end; positions may already be closed.
- Long-only — 13Fs miss shorts, pair trades and cash.
- No non-US / fixed income — the picture is US equities plus options.
- Corporate actions — splits and spinoffs distort raw share deltas.
Newsletter signup
Free subscription. Daily trading day morning dispatch. No spam.